Global Digital Therapeutics Market Set to Flourish, Projected to Reach $17.19 Billion by 2027 As Per The Business Research Company’s Digital Therapeutics Global Market Report 2023

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

LONDON, Nov. 16, 2023 (GLOBE NEWSWIRE) — As per The Business Research Company’s digital therapeutics global market report 2023, the global digital therapeutics market is experiencing remarkable growth, with the market size surging from $5.53 billion in 2022 to $6.93 billion in 2023, marking an impressive compound annual growth rate (CAGR) of 25.1%. Projections indicate continued momentum, with the digital therapeutics market expected to reach $17.19 billion by 2027, reflecting a CAGR of 25.5%.

Segments Driving Growth

The Rising Penetration of Smartphones and Tablets Fueling Market Expansion

One of the primary drivers propelling the digital therapeutics market is the escalating penetration of smartphones and tablets. These portable devices have revolutionized healthcare delivery, making it more convenient and accessible for patients. Digital therapeutics, in the form of mobile applications and software, leverage the power of these devices to provide evidence-based medical interventions, monitor health conditions, and facilitate patient engagement.

In 2023, the estimated global smartphone users reached 5.25 billion, marking a 4.9% annual increase.

Additionally, in the United States, smartphone users increased to 76.5% in 2022, a 3.8% rise from the previous year. The rising prevalence of smartphones and tablets is expected to be a key catalyst for the growth of the digital therapeutics market.

Learn More In-Depth On The Digital Therapeutics Market

Market Concentration and Leading Players

Key Players Driving Market Dynamics

The global digital therapeutics market is fairly concentrated, with a few prominent players shaping the industry. The top ten competitors constituted 34.94% of the total market in 2022. Teladoc Health Inc. led the market with a 19.47% share, followed by Noom (4.21%), Fitbit Health Solutions (3.63%), and others. Market concentration is attributed to strategic acquisitions, partnerships, and global distribution efforts by leading players.

Trends Shaping the Future

Integration of Artificial Intelligence (AI) in Digital Therapeutics

A significant trend gaining popularity in the digital therapeutics market is the introduction of artificial intelligence (AI). Major players are integrating AI into their digital therapeutics software to enhance user experiences and improve patient monitoring and assistance. For example, Fitterfly launched X-Labs, an AI-powered digital therapeutics division, leveraging human-centered design to enhance healthcare quality for patients with chronic conditions. X-Labs utilizes AI for progress tracking, reminders, common requests, and routine information.

Market Segmentation and Leading Regions

Opportunities and Growth Potential

The global digital therapeutics market is segmented based on product, sales channel, and application. Key segments include:

  1. Product: Software, Devices
  2. Sales Channel: Business-To-Business (B2B), Business-To-Consumers (B2C)
  3. Application: Preventive Applications, Treatment or Care-Related Applications

The software segment is poised for significant growth, gaining $14,118.1 million in global annual sales by 2027.

Get A Free Sample Of The Global Digital Therapeutics Market Report

North America emerged as the largest region in the digital therapeutics market in 2022, worth $2,648.3 million. The market accounted for 0.010% of the region’s GDP, with per capita consumption at $5.26—$4.55 higher than the global average. The digital therapeutics market in North America is supported by the high prevalence of chronic diseases and substantial healthcare spending.

As players navigate the dynamic landscape of the digital therapeutics market, the Global Market Report 2023 serves as an invaluable resource. Stakeholders can leverage this comprehensive report to make informed decisions, identify growth opportunities, and stay ahead of industry trends. Strategies for success include expanding business capabilities, investing in AI integration, and capitalizing on the growing demand for digital therapeutics.

Digital Therapeutics Global Market Report 2023 by The Business Research Company provides insights on the digital therapeutics market size, digital therapeutics market segments, digital therapeutics market trends, drivers and restraints, major competitors’ market positioning, revenues and market shares.

The Business Research Company has published over 6,500+ industry reports, covering more than 2,500+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Check Out Similar Market Intelligence Reports By The Business Research Company:

Microbiome Therapeutics Global Market Report 2022

Neurodegenerative Disorder Therapeutics Global Market Report 2023

Antisense & RNAi Therapeutics Global Market Report 2023

Learn More About The Business Research Company

The Business Research Company is a market intelligence firm pioneering in company, market, and consumer research. With offices all around the world, TBRC has specialist consultants in a variety of fields, including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model – World’s Most Comprehensive Database

The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 58 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

CONTACT: The Business Research Company Europe: +44 207 1930 708 Asia: +91 8897263534 Americas: +1 315 623 0293 Email: Follow us on: LinkedIn: Twitter: Facebook: YouTube: Blog: Healthcare Blog: Global Market Model:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.